D-0213-2026 Class II Ongoing
FDA drug recall D-0213-2026 was initiated by Blossom Pharmaceuticals on Oct 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 2400 containers.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 10, 2025
- Initiation Date
- Oct 31, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2400 containers
Product description
Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.
Reason for recall
cGMP deviations
Distribution pattern
USA Nationwide
Code information
Lot #: A482305
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0213-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026